The GvHD Hub spoke with Andrew Harris, Memorial Sloan Kettering Cancer Center, New York, US. We asked, What are the challenges involved in enrolling pediatric patients in cGvHD clinical trials?
During this interview, Harris discusses key barriers to enrolling pediatric patients with chronic graft-versus-host disease (cGvHD) in clinical trials, including the limited number of specialist centers with expertise in managing pediatric cGvHD and the resulting need for some children and their families to travel considerable distances to participating sites. He also highlights how the rarity of cGvHD in children may make it difficult to identify eligible patients for clinical trials.
Intended for healthcare professionals. This educational resource is independently supported by Sanofi. All content is developed by SES in collaboration with an expert steering committee. Funders are allowed no influence.
","author_name":"Scientific Education Support"}